Close Menu

NEW YORK – Prevencio said Tuesday that it has inked an agreement with Microsoft for the sale of Prevencio's cardiac blood tests.

The deal, leveraging Microsoft’s Azure AI-based computing cloud platform and marketing expertise, enables Microsoft Healthcare's salesforce to sell Prevencio's artificial intelligence-based HART cardiac blood tests.

Financial and other terms of the deal were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.